Heartland Group Holdings Limited

HGH.AX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HGH.AX stands at 709.78M. In comparison, AFG.AX has a market cap of 560.49M. Regarding current trading prices, HGH.AX is priced at $0.76, while AFG.AX trades at $2.07.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HGH.AX currently has a P/E ratio of 8.39, whereas AFG.AX's P/E ratio is 18.82. In terms of profitability, HGH.AX's ROE is +0.03%, compared to AFG.AX's ROE of +0.15%. Regarding short-term risk, HGH.AX is more volatile compared to AFG.AX. This indicates potentially higher risk in terms of short-term price fluctuations for HGH.AX.

HGH.AX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HGH.AX stands at 709.78M. In comparison, RMC.AX has a market cap of 336.14M. Regarding current trading prices, HGH.AX is priced at $0.76, while RMC.AX trades at $0.85.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HGH.AX currently has a P/E ratio of 8.39, whereas RMC.AX's P/E ratio is 12.14. In terms of profitability, HGH.AX's ROE is +0.03%, compared to RMC.AX's ROE of +0.07%. Regarding short-term risk, HGH.AX is more volatile compared to RMC.AX. This indicates potentially higher risk in terms of short-term price fluctuations for HGH.AX.

HGH.AX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HGH.AX stands at 709.78M. In comparison, YBR.AX has a market cap of 20.01M. Regarding current trading prices, HGH.AX is priced at $0.76, while YBR.AX trades at $0.06.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HGH.AX currently has a P/E ratio of 8.39, whereas YBR.AX's P/E ratio is -6.10. In terms of profitability, HGH.AX's ROE is +0.03%, compared to YBR.AX's ROE of -0.09%. Regarding short-term risk, HGH.AX is more volatile compared to YBR.AX. This indicates potentially higher risk in terms of short-term price fluctuations for HGH.AX.

HGH.AX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HGH.AX stands at 709.78M. In comparison, N1H.AX has a market cap of 10.57M. Regarding current trading prices, HGH.AX is priced at $0.76, while N1H.AX trades at $0.12.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HGH.AX currently has a P/E ratio of 8.39, whereas N1H.AX's P/E ratio is 12.00. In terms of profitability, HGH.AX's ROE is +0.03%, compared to N1H.AX's ROE of +0.63%. Regarding short-term risk, HGH.AX is more volatile compared to N1H.AX. This indicates potentially higher risk in terms of short-term price fluctuations for HGH.AX.